ResMed | RMD - Interest Expense On Debt


ResMed reported $8.79M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Ansell USD 20.9M 1.1M Jun/2025
Artivion USD 7.83M 1.22M Mar/2024
AtriCure USD 1.33M 17K Sep/2025
Baxter International USD 58M 14M Sep/2025
Cochlear AUD 2.65M 3.05M Jun/2025
Cooper Companies USD 24.4M 1000K Sep/2025
CSL USD 104M 136M Jun/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Fisher Paykel Healthcare NZD 5.5M 700K Dec/2025
Globus Medical USD 5.1B 5.1B Sep/2025
Haemonetics USD 7.21M 3.14M Sep/2025
Hologic USD 27.6M 1000K Dec/2025
Idexx Laboratories USD 10.08M 1.24M Sep/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 22.72M 1.68M Sep/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
Masimo USD 8.8M 600K Sep/2025
Medtronic USD 181M 0 Dec/2025
Philips EUR 109M 31M Dec/2025
Ramsay Health Care AUD 316.1M 10.4M Jun/2025
ResMed USD 8.79M 14.55M Sep/2025
Sigma Healthcare AUD 7.97M 365K Jan/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Steris USD 14.9M 0 Dec/2025
Teleflex USD 31.84M 10.13M Sep/2025
Thermo Fisher Scientific USD 365M 18M Dec/2025